https://www.selleckchem.com/pr....oducts/epalrestat.ht
Hospital admissions and ED visits were not significantly affected by any interventions. CONCLUSIONS Apps and educational toolkits improved patient knowledge. Pathways increased patient quality of life and provider prescription rates. There is a need for more research to determine the AF transition interventions which maximise patient, provider and health care outcomes. BACKGROUND Myocarditis is an inflammation of the heart muscle and an important cause of dilated cardiomyopathy. Its presentation is heterogeneous, and there are limite